| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunologic Deficiency Syndromes | 16 | 2024 | 238 | 3.460 |
Why?
|
| DiGeorge Syndrome | 8 | 2023 | 77 | 1.920 |
Why?
|
| Thymus Gland | 8 | 2013 | 294 | 1.690 |
Why?
|
| Genetic Testing | 5 | 2021 | 1589 | 1.560 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 5 | 2021 | 184 | 1.150 |
Why?
|
| Severe Combined Immunodeficiency | 5 | 2018 | 107 | 0.930 |
Why?
|
| Killer Cells, Natural | 8 | 2024 | 904 | 0.920 |
Why?
|
| RGS Proteins | 1 | 2021 | 61 | 0.790 |
Why?
|
| Body Height | 1 | 2021 | 231 | 0.740 |
Why?
|
| Parathyroid Glands | 2 | 2011 | 127 | 0.740 |
Why?
|
| Transplantation Tolerance | 2 | 2010 | 15 | 0.700 |
Why?
|
| Herpesvirus 4, Human | 3 | 2021 | 966 | 0.520 |
Why?
|
| Granulomatous Disease, Chronic | 3 | 2020 | 79 | 0.520 |
Why?
|
| Cytomegalovirus | 1 | 2018 | 482 | 0.500 |
Why?
|
| Mutation | 15 | 2022 | 15179 | 0.500 |
Why?
|
| Gain of Function Mutation | 4 | 2018 | 126 | 0.490 |
Why?
|
| T-Lymphocyte Subsets | 4 | 2016 | 582 | 0.480 |
Why?
|
| Cytomegalovirus Infections | 1 | 2018 | 462 | 0.470 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2020 | 2291 | 0.470 |
Why?
|
| Sirolimus | 1 | 2018 | 814 | 0.460 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2018 | 489 | 0.450 |
Why?
|
| Haploinsufficiency | 3 | 2023 | 294 | 0.450 |
Why?
|
| Phenotype | 10 | 2021 | 6295 | 0.430 |
Why?
|
| Lymphatic System | 1 | 2012 | 64 | 0.420 |
Why?
|
| Genomics | 3 | 2022 | 2738 | 0.420 |
Why?
|
| Transplantation, Homologous | 4 | 2011 | 2843 | 0.400 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2020 | 5539 | 0.400 |
Why?
|
| Forkhead Transcription Factors | 2 | 2013 | 778 | 0.400 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2018 | 1678 | 0.390 |
Why?
|
| Agammaglobulinemia | 2 | 2021 | 46 | 0.390 |
Why?
|
| Infant | 19 | 2023 | 13310 | 0.370 |
Why?
|
| Genome, Human | 1 | 2018 | 1869 | 0.350 |
Why?
|
| Actins | 2 | 2024 | 608 | 0.340 |
Why?
|
| Common Variable Immunodeficiency | 2 | 2020 | 30 | 0.330 |
Why?
|
| Humans | 63 | 2024 | 261506 | 0.320 |
Why?
|
| B-Lymphocytes | 5 | 2021 | 1294 | 0.320 |
Why?
|
| Lymphoproliferative Disorders | 2 | 2021 | 366 | 0.320 |
Why?
|
| STAT1 Transcription Factor | 2 | 2018 | 156 | 0.300 |
Why?
|
| Carrier Proteins | 3 | 2021 | 2022 | 0.290 |
Why?
|
| Alleles | 7 | 2020 | 2437 | 0.290 |
Why?
|
| Genetic Association Studies | 6 | 2021 | 1084 | 0.290 |
Why?
|
| Immunophenotyping | 5 | 2018 | 1681 | 0.270 |
Why?
|
| Autoimmune Diseases | 2 | 2019 | 402 | 0.260 |
Why?
|
| Membrane Proteins | 3 | 2020 | 2819 | 0.250 |
Why?
|
| Child, Preschool | 16 | 2023 | 16273 | 0.250 |
Why?
|
| Hypersensitivity | 2 | 2024 | 216 | 0.240 |
Why?
|
| Dermatitis | 1 | 2024 | 60 | 0.240 |
Why?
|
| Phospholipase C gamma | 1 | 2023 | 54 | 0.230 |
Why?
|
| Aging | 1 | 2012 | 1582 | 0.230 |
Why?
|
| Heterozygote | 4 | 2020 | 1020 | 0.230 |
Why?
|
| CHARGE Syndrome | 1 | 2023 | 11 | 0.230 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2023 | 60 | 0.220 |
Why?
|
| Pedigree | 7 | 2021 | 1890 | 0.220 |
Why?
|
| Child | 19 | 2023 | 29154 | 0.220 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2022 | 1146 | 0.210 |
Why?
|
| Arthritis | 2 | 2020 | 139 | 0.210 |
Why?
|
| Disease Management | 2 | 2018 | 1052 | 0.200 |
Why?
|
| Hereditary Autoinflammatory Diseases | 1 | 2021 | 7 | 0.200 |
Why?
|
| Nonsense Mediated mRNA Decay | 2 | 2018 | 38 | 0.200 |
Why?
|
| Neutropenia | 2 | 2022 | 968 | 0.190 |
Why?
|
| Minichromosome Maintenance Proteins | 1 | 2020 | 10 | 0.190 |
Why?
|
| Colitis | 1 | 2024 | 340 | 0.190 |
Why?
|
| Homozygote | 2 | 2020 | 717 | 0.190 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 47 | 0.190 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2020 | 68 | 0.190 |
Why?
|
| X-Linked Combined Immunodeficiency Diseases | 1 | 2020 | 4 | 0.180 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 538 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2021 | 179 | 0.180 |
Why?
|
| Autoimmune Lymphoproliferative Syndrome | 1 | 2020 | 6 | 0.180 |
Why?
|
| Mutation, Missense | 3 | 2020 | 1152 | 0.180 |
Why?
|
| Male | 30 | 2021 | 123000 | 0.180 |
Why?
|
| Magnesium Deficiency | 1 | 2020 | 21 | 0.180 |
Why?
|
| GTP-Binding Proteins | 1 | 2021 | 321 | 0.180 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2023 | 362 | 0.180 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2019 | 42 | 0.180 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2019 | 16 | 0.170 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2019 | 69 | 0.170 |
Why?
|
| Infant, Newborn | 6 | 2022 | 8223 | 0.170 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2021 | 192 | 0.170 |
Why?
|
| DNA Copy Number Variations | 3 | 2021 | 1516 | 0.170 |
Why?
|
| Sepsis | 2 | 2021 | 652 | 0.170 |
Why?
|
| Lymphopoiesis | 2 | 2021 | 17 | 0.170 |
Why?
|
| Female | 29 | 2021 | 141928 | 0.170 |
Why?
|
| Lymphopenia | 1 | 2021 | 199 | 0.170 |
Why?
|
| Sequence Analysis, DNA | 3 | 2016 | 2483 | 0.160 |
Why?
|
| Whole Genome Sequencing | 1 | 2020 | 338 | 0.160 |
Why?
|
| Osteochondrodysplasias | 1 | 2019 | 77 | 0.160 |
Why?
|
| Biliary Tract Diseases | 1 | 2018 | 61 | 0.160 |
Why?
|
| Guanylate Cyclase | 1 | 2018 | 74 | 0.160 |
Why?
|
| Immunological Synapses | 1 | 2018 | 28 | 0.160 |
Why?
|
| Immunologic Memory | 1 | 2020 | 374 | 0.160 |
Why?
|
| Nuclear Proteins | 3 | 2020 | 3343 | 0.160 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2019 | 82 | 0.160 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2018 | 106 | 0.160 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2021 | 461 | 0.160 |
Why?
|
| Immune System Diseases | 1 | 2018 | 65 | 0.160 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 488 | 0.160 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2018 | 113 | 0.160 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 233 | 0.160 |
Why?
|
| Alemtuzumab | 1 | 2018 | 198 | 0.150 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 148 | 0.150 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 621 | 0.150 |
Why?
|
| Viremia | 1 | 2018 | 177 | 0.150 |
Why?
|
| Adolescent | 12 | 2021 | 31252 | 0.150 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 264 | 0.150 |
Why?
|
| Models, Immunological | 2 | 2020 | 77 | 0.150 |
Why?
|
| Interferon Regulatory Factors | 1 | 2016 | 76 | 0.140 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2021 | 413 | 0.140 |
Why?
|
| DNA Damage | 3 | 2020 | 1954 | 0.140 |
Why?
|
| Data Interpretation, Statistical | 1 | 2018 | 482 | 0.140 |
Why?
|
| Cell Line | 5 | 2024 | 5114 | 0.140 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2014 | 173 | 0.140 |
Why?
|
| Coatomer Protein | 1 | 2016 | 35 | 0.140 |
Why?
|
| Immunoglobulins | 1 | 2016 | 266 | 0.140 |
Why?
|
| Chromosome Breakage | 1 | 2016 | 226 | 0.140 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2016 | 180 | 0.130 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2018 | 521 | 0.130 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 4 | 2023 | 6550 | 0.130 |
Why?
|
| Chromatin | 1 | 2021 | 942 | 0.130 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2018 | 675 | 0.130 |
Why?
|
| Cell Differentiation | 4 | 2021 | 4078 | 0.130 |
Why?
|
| Microscopy, Confocal | 1 | 2018 | 663 | 0.130 |
Why?
|
| Codon, Nonsense | 3 | 2021 | 164 | 0.130 |
Why?
|
| Trans-Activators | 1 | 2021 | 1555 | 0.120 |
Why?
|
| Neonatal Screening | 1 | 2015 | 165 | 0.120 |
Why?
|
| Diagnosis, Differential | 3 | 2021 | 4744 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2018 | 1265 | 0.120 |
Why?
|
| Heart Defects, Congenital | 2 | 2023 | 1697 | 0.120 |
Why?
|
| Computational Biology | 1 | 2020 | 1271 | 0.120 |
Why?
|
| Parents | 2 | 2011 | 998 | 0.120 |
Why?
|
| Lung Diseases | 2 | 2016 | 717 | 0.120 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2013 | 33 | 0.120 |
Why?
|
| Syndrome | 4 | 2021 | 1351 | 0.120 |
Why?
|
| Intellectual Disability | 1 | 2021 | 1032 | 0.120 |
Why?
|
| Epilepsy | 1 | 2021 | 883 | 0.110 |
Why?
|
| Genetic Variation | 2 | 2019 | 2086 | 0.110 |
Why?
|
| Liver Diseases | 1 | 2018 | 574 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2020 | 1033 | 0.110 |
Why?
|
| Virus Diseases | 1 | 2016 | 398 | 0.110 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 1688 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2019 | 5637 | 0.110 |
Why?
|
| Chromosome Deletion | 2 | 2023 | 1005 | 0.110 |
Why?
|
| Amino Acid Substitution | 3 | 2020 | 644 | 0.110 |
Why?
|
| Abnormalities, Multiple | 2 | 2016 | 998 | 0.100 |
Why?
|
| Clone Cells | 1 | 2013 | 555 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 2488 | 0.100 |
Why?
|
| NF-kappa B | 1 | 2019 | 1549 | 0.100 |
Why?
|
| Autophagy | 1 | 2018 | 927 | 0.100 |
Why?
|
| Asthma | 1 | 2019 | 871 | 0.100 |
Why?
|
| Genes, MHC Class II | 1 | 2011 | 67 | 0.100 |
Why?
|
| Animals | 10 | 2023 | 59536 | 0.100 |
Why?
|
| Postoperative Period | 1 | 2013 | 665 | 0.100 |
Why?
|
| Cell Hypoxia | 1 | 2012 | 328 | 0.100 |
Why?
|
| Cytokines | 1 | 2020 | 2809 | 0.100 |
Why?
|
| Autoimmunity | 2 | 2024 | 263 | 0.100 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2010 | 88 | 0.100 |
Why?
|
| Lymphoma | 1 | 2019 | 1467 | 0.100 |
Why?
|
| Pseudolymphoma | 1 | 2010 | 22 | 0.100 |
Why?
|
| Transcription Factors | 2 | 2022 | 5270 | 0.090 |
Why?
|
| Cell Lineage | 1 | 2013 | 668 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2010 | 169 | 0.090 |
Why?
|
| Family | 3 | 2020 | 736 | 0.090 |
Why?
|
| Inflammation | 4 | 2024 | 2522 | 0.090 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2010 | 182 | 0.090 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 3251 | 0.090 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 2265 | 0.090 |
Why?
|
| Chromosomes | 2 | 2023 | 244 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2021 | 9244 | 0.090 |
Why?
|
| Immune Tolerance | 1 | 2011 | 403 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 673 | 0.080 |
Why?
|
| Histocompatibility Testing | 1 | 2010 | 447 | 0.080 |
Why?
|
| Pyrazoles | 1 | 2017 | 1471 | 0.080 |
Why?
|
| BRCA2 Protein | 1 | 2010 | 358 | 0.080 |
Why?
|
| Models, Animal | 1 | 2011 | 664 | 0.080 |
Why?
|
| Adult | 10 | 2021 | 77950 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2021 | 6869 | 0.080 |
Why?
|
| Risk Factors | 3 | 2021 | 17523 | 0.080 |
Why?
|
| Immunity, Innate | 1 | 2012 | 677 | 0.080 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 2045 | 0.080 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2022 | 362 | 0.070 |
Why?
|
| Young Adult | 7 | 2021 | 21445 | 0.070 |
Why?
|
| Mice | 7 | 2023 | 34495 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2023 | 11965 | 0.070 |
Why?
|
| Graft Survival | 1 | 2010 | 1062 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2012 | 1129 | 0.070 |
Why?
|
| DNA Replication | 2 | 2022 | 744 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2021 | 1489 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 4053 | 0.070 |
Why?
|
| Bone Marrow | 1 | 2012 | 2358 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2021 | 6100 | 0.060 |
Why?
|
| Mice, Knockout | 3 | 2019 | 5710 | 0.060 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2023 | 18 | 0.060 |
Why?
|
| Janus Kinase 1 | 1 | 2024 | 121 | 0.060 |
Why?
|
| Biological Variation, Population | 1 | 2023 | 22 | 0.060 |
Why?
|
| Tissue Donors | 1 | 2007 | 769 | 0.060 |
Why?
|
| United States | 1 | 2019 | 15433 | 0.050 |
Why?
|
| Herpesviridae Infections | 1 | 2023 | 175 | 0.050 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2021 | 16 | 0.050 |
Why?
|
| Exome | 2 | 2018 | 1239 | 0.050 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2021 | 35 | 0.050 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2020 | 7 | 0.050 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2020 | 7 | 0.050 |
Why?
|
| Consanguinity | 1 | 2021 | 114 | 0.050 |
Why?
|
| Joints | 1 | 2020 | 47 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2019 | 1682 | 0.050 |
Why?
|
| Prognosis | 1 | 2018 | 21713 | 0.050 |
Why?
|
| DNA-Binding Proteins | 3 | 2022 | 4821 | 0.050 |
Why?
|
| Uniparental Disomy | 1 | 2021 | 66 | 0.050 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 132 | 0.050 |
Why?
|
| Cytidine Deaminase | 1 | 2020 | 83 | 0.050 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 182 | 0.050 |
Why?
|
| CD4-CD8 Ratio | 1 | 2020 | 58 | 0.050 |
Why?
|
| India | 1 | 2020 | 301 | 0.040 |
Why?
|
| Genotype | 2 | 2019 | 4109 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2021 | 259 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2019 | 171 | 0.040 |
Why?
|
| Glycosylation | 1 | 2020 | 213 | 0.040 |
Why?
|
| T-Lymphocytes | 3 | 2022 | 3869 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2021 | 700 | 0.040 |
Why?
|
| Immunity | 1 | 2021 | 342 | 0.040 |
Why?
|
| Candidiasis, Chronic Mucocutaneous | 1 | 2018 | 5 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2024 | 731 | 0.040 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2020 | 278 | 0.040 |
Why?
|
| Busulfan | 1 | 2023 | 764 | 0.040 |
Why?
|
| Liver | 1 | 2009 | 2961 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2020 | 32848 | 0.040 |
Why?
|
| Autophagy-Related Protein-1 Homolog | 1 | 2018 | 10 | 0.040 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 203 | 0.040 |
Why?
|
| Cell Division | 1 | 2022 | 2489 | 0.040 |
Why?
|
| Machine Learning | 1 | 2021 | 319 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 829 | 0.040 |
Why?
|
| Cation Transport Proteins | 1 | 2020 | 199 | 0.040 |
Why?
|
| Ferritins | 1 | 2018 | 151 | 0.040 |
Why?
|
| Chimerism | 1 | 2018 | 63 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2021 | 560 | 0.040 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2018 | 35 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2018 | 237 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 115 | 0.040 |
Why?
|
| ROC Curve | 1 | 2021 | 1183 | 0.040 |
Why?
|
| Pancytopenia | 1 | 2018 | 120 | 0.040 |
Why?
|
| Proteome | 1 | 2021 | 561 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2018 | 220 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 1077 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2021 | 1144 | 0.040 |
Why?
|
| Mutant Proteins | 1 | 2018 | 234 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2021 | 351 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 461 | 0.040 |
Why?
|
| Multiple Organ Failure | 1 | 2018 | 177 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2018 | 250 | 0.040 |
Why?
|
| Biomarkers | 2 | 2020 | 5047 | 0.040 |
Why?
|
| CD56 Antigen | 1 | 2016 | 83 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 388 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 544 | 0.040 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2018 | 204 | 0.040 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2016 | 36 | 0.040 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 334 | 0.040 |
Why?
|
| Unrelated Donors | 1 | 2018 | 304 | 0.040 |
Why?
|
| Janus Kinases | 1 | 2017 | 174 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2016 | 86 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2021 | 1021 | 0.030 |
Why?
|
| Chromosome Segregation | 1 | 2016 | 82 | 0.030 |
Why?
|
| Zebrafish | 1 | 2019 | 463 | 0.030 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2016 | 45 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2021 | 1442 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2023 | 3001 | 0.030 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 674 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2020 | 7226 | 0.030 |
Why?
|
| Meiosis | 1 | 2016 | 166 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 128 | 0.030 |
Why?
|
| Seizures | 1 | 2021 | 989 | 0.030 |
Why?
|
| Cause of Death | 1 | 2018 | 752 | 0.030 |
Why?
|
| Family Health | 1 | 2016 | 325 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2016 | 242 | 0.030 |
Why?
|
| Binding Sites | 1 | 2019 | 2171 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2018 | 589 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2018 | 745 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2021 | 1242 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 1498 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2021 | 1085 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2020 | 1385 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2021 | 1171 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 1021 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2019 | 1732 | 0.030 |
Why?
|
| Exons | 1 | 2018 | 1328 | 0.030 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2014 | 47 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2020 | 1375 | 0.030 |
Why?
|
| Stem Cells | 1 | 2021 | 1213 | 0.030 |
Why?
|
| Complementarity Determining Regions | 1 | 2014 | 43 | 0.030 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2014 | 102 | 0.030 |
Why?
|
| Mitosis | 1 | 2016 | 615 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2016 | 613 | 0.030 |
Why?
|
| Time Factors | 1 | 2007 | 12926 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 7551 | 0.030 |
Why?
|
| Neoplasms | 1 | 2019 | 15193 | 0.030 |
Why?
|
| Nitriles | 1 | 2017 | 906 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2021 | 929 | 0.030 |
Why?
|
| Protein Binding | 1 | 2019 | 3438 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2018 | 2283 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2019 | 1360 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2020 | 4804 | 0.030 |
Why?
|
| Base Sequence | 1 | 2018 | 4917 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 1085 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2016 | 691 | 0.020 |
Why?
|
| Texas | 1 | 2021 | 6311 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 612 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 8865 | 0.020 |
Why?
|
| DNA Repair | 1 | 2016 | 1872 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 1143 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 12873 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2018 | 6150 | 0.020 |
Why?
|
| ABO Blood-Group System | 1 | 2008 | 127 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 7222 | 0.020 |
Why?
|
| Incidence | 1 | 2018 | 5673 | 0.020 |
Why?
|
| Disease Progression | 1 | 2018 | 6682 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 2403 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2007 | 684 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2008 | 546 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2017 | 3518 | 0.020 |
Why?
|
| Skin | 1 | 2010 | 1259 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 14551 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 3033 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 14889 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2018 | 37905 | 0.010 |
Why?
|
| Aged | 2 | 2016 | 70117 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2010 | 2967 | 0.010 |
Why?
|
| Middle Aged | 2 | 2016 | 86204 | 0.010 |
Why?
|
| Biopsy | 1 | 2007 | 3443 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6207 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2007 | 9180 | 0.010 |
Why?
|